Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, J Munday, ... Science 372, eabg3055, 2021 | 2944* | 2021 |
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study K Prem, Y Liu, TW Russell, AJ Kucharski, RM Eggo, N Davies, S Flasche, ... The Lancet Public Health 5 (5), e261-e270, 2020 | 2588 | 2020 |
Age-dependent effects in the transmission and control of COVID-19 epidemics NG Davies, P Klepac, Y Liu, K Prem, M Jit, CC group, RM Eggo Nature Medicine 26, 1205–1211, 2020 | 2111 | 2020 |
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 NG Davies, CI Jarvis, WJ Edmunds, NP Jewell, K Diaz-Ordaz, RH Keogh, ... Nature 593, 270–274, 2021 | 1129 | 2021 |
Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis RM Viner, OT Mytton, C Bonell, GJ Melendez-Torres, J Ward, L Hudson, ... JAMA Pediatrics 175 (2), 143–156, 2020 | 1104 | 2020 |
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study NG Davies, AJ Kucharski, RM Eggo, A Gimma, WJ Edmunds, T Jombart, ... The Lancet Public Health 5 (7), e375-e385, 2020 | 915 | 2020 |
Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era K Prem, K Zandvoort, P Klepac, RM Eggo, NG Davies, ... PLOS Computational Biology 17 (7), e1009098, 2021 | 166 | 2021 |
Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study NG Davies, RC Barnard, CI Jarvis, TW Russell, MG Semple, M Jit, ... The Lancet Infectious Diseases 21 (4), 482-492, 2021 | 154 | 2021 |
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic … FG Sandmann, NG Davies, A Vassall, WJ Edmunds, M Jit, FY Sun, ... The Lancet Infectious Diseases 21 (7), 962-974, 2021 | 153 | 2021 |
Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y CAB Pearson, TW Russell, N Davies, AJ Kucharski, ... V2 in South Africa, 2021 | 120* | 2021 |
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study K Van Zandvoort, CI Jarvis, CAB Pearson, NG Davies, R Ratnayake, ... BMC medicine 18 (1), 324, 2020 | 114 | 2020 |
Enforcement is central to the evolution of cooperation JA Ågren, NG Davies, KR Foster Nature Ecology & Evolution 3 (7), 1018–1029, 2019 | 108 | 2019 |
Within-host dynamics shape antibiotic resistance in commensal bacteria NG Davies, S Flasche, M Jit, KE Atkins Nature Ecology & Evolution 3 (3), 440-449, 2019 | 101 | 2019 |
The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study T Leng, C White, J Hilton, A Kucharski, L Pellis, H Stage, NG Davies, ... Wellcome Open Research 5 (213), 213, 2020 | 70 | 2020 |
Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance KE Atkins, EI Lafferty, SR Deeny, NG Davies, JV Robotham, M Jit The Lancet Infectious Diseases 18 (6), e204–e213, 2018 | 66 | 2018 |
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness CAB Pearson, F Bozzani, SR Procter, NG Davies, M Huda, HT Jensen, ... PLoS medicine 18 (10), e1003815, 2021 | 61* | 2021 |
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era RC Barnard, NG Davies, M Jit, WJ Edmunds Nature Communications 13 (1), 1-15, 2022 | 52 | 2022 |
Mathematical modelling for antibiotic resistance control policy: do we know enough? GM Knight, NG Davies, C Colijn, F Coll, T Donker, DR Gifford, RE Glover, ... BMC Infectious Diseases 19 (1), 1011, 2019 | 52 | 2019 |
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa CAB Pearson, SP Silal, MWZ Li, J Dushoff, BM Bolker, S Abbott, ... MedRxiv, 2021.12. 19.21268038, 2021 | 50 | 2021 |
Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022 RC Barnard, NG Davies, CAB Pearson, M Jit, WJ Edmunds medRxiv, 2021 | 36 | 2021 |